Roswell Park is one of very few institutions in the United States equipped to offer clinical trials of a full range of immunotherapies. How do these treatments work, and what new immunotherapy clinical trials are underway or close to being launched?
“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."
Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells.
Ten years ago, patients diagnosed with advanced-stage kidney cancer had few options, and none of them were very promising. But in recent years, we have seen a revolution in kidney cancer treatment with ten new targeted drugs winning FDA approval.
When it comes to medical treatments, we’re not all alike. Women and men sometimes need different dosages of the same drug. One drug for heart failure works very well in black patients but not in white patients.
Igor Puzanov, MD, has dedicated his life to finding a cure for cancer. In 1992, he left the Czech Republic and moved to Dallas, Texas to train in immunology at the University of Southwestern and in internal medicine at Parkland Memorial Hospital – best known for treating President John F. Kennedy.
During the Buffalo Cancer Moonshot Summit, Roswell Park joined a national conversation on how to end cancer as we know it. This initiative, backed by Vice President Joe Biden, intends to double the speed of cancer research and remove barriers to clinical trials by improving access to information.
Roswell Park Cancer Institute made national headlines last April in securing an agreement to bring Cuba’s encouraging lung cancer vaccine, CIMAvax, to the United States for clinical testing. Nearly one year later, Cuba is back in the news and CIMAvax is receiving renewed attention. One of the most frequently asked questions about this vaccine is, “When will it be available for lung cancer patients in the U.S.?”
Something very big is happening in the field of clinical trials (also called clinical research studies). It’s moving fast, and it will have far-reaching effects on the future of cancer research and treatment.